Report copyright - CENTER FOR DRUG EVALUATION AND RESEARCH · Sandoz submitted the 351(k) BLA 761045 requesting marketing approval for LA-EP2006, a proposed biosimilar to the reference product US-licensed
Please pass captcha verification before submit form